Arthralgia Clinical Trial
Official title:
The Use of Viscosupplementation for the Treatment of Patients With Persistent Non-mechanical Pain Status-post Partial Menisectomy
The investigators' objective is to analyze a group of patients who have had a partial meniscectomy but continue to have knee pain after surgery with a double-blind, randomized prospective study comparing the use of Hylan G-F 20(single injection of a viscosupplementation) versus placebo injection. The investigators would expect patients who receive the treatment (Hylan G-F 20) to have lower pain compared to the patients who were in the placebo group (had the needle injected into the knee but no medication or substance injected) since Hylan G-F 20 has been shown to decrease pain in arthritic patients.
A great majority of patients who have a partial menisectomy for mechanical symptoms do well with full return of function without pain. There is a sub-group of patients who are found to have Grade II- III chondromalacia lesions (deemed arthritic) at the time of surgery that have persistent generalized "arthritic-type" pain despite relief of their mechanical symptoms. To date, there are no published studies analyzing if this treatment is better than no treatment in this group of patients. We would expect patients who receive the treatment (Hylan G-F 20) to have lower pain compared to the patients who were in the placebo group (had the needle injected into the knee but no medication or substance injected) since Hylan G-F 20 has been shown to decrease pain in arthritic patients. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03802578 -
The Impact of Exercise on Hand Function, Daily Activities Performance and Quality of Life of SLE' Patients
|
N/A | |
Completed |
NCT01896050 -
Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer
|
N/A | |
Recruiting |
NCT04354649 -
Immune-Mediated Pathophysiology And Clinical Triage Program
|
Phase 2 | |
Terminated |
NCT00973141 -
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain
|
Phase 2 | |
Recruiting |
NCT05564182 -
High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain
|
N/A | |
Recruiting |
NCT05033613 -
Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease
|
||
Recruiting |
NCT03953157 -
Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors
|
N/A | |
Not yet recruiting |
NCT06001125 -
Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)
|
Phase 2 | |
Terminated |
NCT02947022 -
Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease
|
Phase 1/Phase 2 | |
Terminated |
NCT02047851 -
Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis
|
N/A | |
Withdrawn |
NCT01612728 -
Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer
|
Phase 2 | |
Completed |
NCT02118636 -
Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms
|
N/A | |
Completed |
NCT00416715 -
Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer
|
Phase 2 | |
Completed |
NCT00361582 -
A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery
|
Phase 3 | |
Completed |
NCT02831582 -
Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer
|
N/A | |
Recruiting |
NCT04494412 -
An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection
|
Phase 2 | |
Not yet recruiting |
NCT06134050 -
Finding the Optimal Aim of Correction in Opening Wedge High Tibial Osteotomy
|
N/A | |
Completed |
NCT02589249 -
The Effect of AyuFlex® Supplementation on Joint Health
|
N/A | |
Completed |
NCT02778906 -
Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia
|
Phase 3 | |
Terminated |
NCT01096407 -
Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel
|
Phase 1 |